Clinical Trials Using BRAF Inhibitor PLX8394
Clinical trials are research studies that involve people. The clinical trials on this list are studying BRAF Inhibitor PLX8394. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
A Study of PLX8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors
The objective of this study is to determine the safety, pharmacokinetics, maximum tolerated dose / recommended Phase 2 dose, and efficacy of PLX8394.
Location: Memorial Sloan Kettering Cancer Center, New York, New York